文献速递血栓与止血造血干细胞移植与细胞治疗

氨甲环酸调节无纤溶亢进小鼠创伤性脑损伤后的细胞免疫谱

Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis.
PubMed 文献 · J Thromb Haemost · 2019-09-03

研究在小鼠创伤性脑损伤(TBI)模型中评估纤溶酶和氨甲环酸(TXA)对免疫反应的影响。结果显示,纤溶酶原缺陷或TXA治疗可增加颈部引流淋巴结(cLN)中抗原提呈细胞和T细胞的迁移与增殖,且不增强中枢神经系统自身反应性。

要点

  • 纤溶酶原缺陷小鼠TBI后1周cLN中抗原提呈细胞和T细胞数量及活化增加。
  • 野生型小鼠TXA治疗同样增加cLN细胞数及固有和适应性免疫细胞。
  • 上述变化发生于无全身性纤溶亢进或凝血病的情况下。

核心结论

  • 在无全身性纤溶亢进时,纤溶酶缺陷或TXA阻断可增加TBI后cLN中常规树突状细胞(cDCs)及多种抗原提呈细胞和T细胞的迁移与增殖。
  • TXA可能对调节TBI后炎症和免疫反应具有临床益处,且不促进中枢神经系统自身反应性。

研究设计与样本

  • 研究纳入野生型和纤溶酶原缺陷(plg-/-)小鼠,实施TBI后评估免疫反应。
  • 采用流式细胞术检测淋巴结和脑内白细胞亚群,血细胞计数仪检测血液白细胞。
  • 采用酶联免疫斑点(ELISpot)法测定对中枢神经系统抗原的免疫反应性。
  • 采用血栓弹力图及检测D-二聚体和纤溶酶-抗纤溶酶复合物水平评估纤溶。

主要发现

  • plg-/-小鼠而非plg+/+小鼠在TBI后1周cLN中多种抗原提呈细胞和T细胞的数量与活化均增加。
  • 野生型小鼠接受TXA治疗后TBI后1周cLN细胞数增加,同时固有和适应性免疫细胞增加。
  • 这些变化发生于该TBI模型无全身性纤溶亢进或凝血病的情况下。
  • 纤溶酶缺陷或TXA治疗均未增强中枢神经系统内的自身反应性。

临床怎么用

  • TXA可能用于调节TBI后炎症和免疫反应,且不促进中枢神经系统自身反应性。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Traumatic brain injury (TBI) is known to promote immunosuppression, making patients more susceptible to infection, yet potentially exerting protective effects by inhibiting central nervous system (CNS) reactivity. Plasmin, the effector protease of the fibrinolytic system, is now recognized for its involvement in modulating immune function. OBJECTIVE: To evaluate the effects of plasmin and tranexamic acid (TXA) on the immune response in wild-type and plasminogen-deficient (plg-/- ) mice subjected to TBI. METHODS: Leukocyte subsets in lymph nodes and the brain in mice post TBI were evaluated by flow cytometry and in blood with a hemocytometer. Immune responsiveness to CNS antigens was determined by Enzyme-linked Immunosorbent Spot (ELISpot) assay. Fibrinolysis was determined by thromboelastography and measuring D-dimer and plasmin-antiplasmin complex levels. RESULTS: Plg-/- mice, but not plg+/+ mice displayed increases in both the number and activation of various antigen-presenting cells and T cells in the cLN 1 week post TBI. Wild-type mice treated with TXA also displayed increased cellularity of the cLN 1 week post TBI together with increases in innate and adaptive immune cells. These changes occurred despite the absence of systemic hyperfibrinolysis or coagulopathy in this model of TBI. Importantly, neither plg deficiency nor TXA treatment enhanced the autoreactivity within the CNS. CONCLUSION: In the absence of systemic hyperfibrinolysis, plasmin deficiency or blockade with TXA increases migration and proliferation of conventional dendritic cells (cDCs) and various antigen-presenting cells and T cells in the draining cervical lymph node (cLN) post TBI. Tranexamic acid might also be clinically beneficial in modulating the inflammatory and immune response after TBI, but without promoting CNS autoreactivity.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Draxler DF, Daglas M, Fernando A, et al. Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis. J Thromb Haemost. 2019. PMID: 31393041. doi:10.1111/jth.14603

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。